Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ISRG stock hub

Intuitive Surgical maintains a dominant, near-monopoly position in soft-tissue robotic surgery. Its massive installed base of da Vinci systems creates a razor-and-blade model with high switching costs, generating robust recurring revenues from instruments and accessories. Strong free cash flow generation and high ROIC solidify its status as a premier quality compounder.

Read full analysis Valuation Archive

Fair value midpoint

$255

$176 - $337

Upside to midpoint

-43.4%

Based on latest report

Confidence

87/100

Data quality and model convergence

Market cap

$159.4B

NASDAQ

Our take

Research highlights

What our analysis says

Pulled from the latest published report. The full reasoning lives under /analysis.

Biggest opportunity

Bull case

Bull: Flawless execution of new product pipelines and sustained international expansion justify a premium 30x+ multiple, reaching internal valuation cross-checks expected value.

Biggest risk

Medtronic/J&J Capture 30% Market Share

2-3 Years

Recommended action

Sell

Sell. The 56% divergence from internal valuation cross-checks signals heavy market premium; intrinsic baseline valuation is $254.67.

Market data

Price

Recent price action with selectable time range.

Intuitive Surgical, Inc.ISRG

—

Loading chart…

In the news

Latest news · ISRG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Analysis map

Jump into the research surface

These links all point into /analysis/*, so a hub rollback leaves the report reader and legacy redirects live.

Forecast

Targets

Bull, base, and bear cases with expected-return framing.

Valuation

Models

Fair-value bridge, DCF, owner earnings, and peer multiples.

Sensitivity

Grid

Cost-of-equity and terminal-growth stress table.

Risks

Bear case

Kill scenarios, soft-pass flags, and downside catalysts.

Earnings

Decision tree

Next earnings setup and beat / inline / miss thresholds.

Position sizing

Checkpoints

Entry, exit, conviction, and quarterly monitoring rules.

Financials

History

Revenue, margins, cash flow, and balance-sheet context.

Peers

Comps

Relative valuation and profitability against the cohort.

Moat

Durability

Economic-profit evidence and competitive advantage risk.

Industry cycle

Context

Sector phase, capital cycle, and secular tailwinds.

Scorecard

Factors

Six-factor overlay and 9-category weighted scorecard.

Recommendation

Verdict

Final action, action steps, opportunity, and biggest risk.

Perspectives

Lenses

Growth, value, and income investor reads.

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E38.2

P25 n/aP50 n/aP75 n/a

Trailing P/E0

P25 n/aP50 n/aP75 n/a

ROE17.2

P25 n/aP50 n/aP75 n/a

ROIC21.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Our take

Indicator catalog

All ISRG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001035267
Company name	Intuitive Surgical, Inc.
Country	United States
Country code	US
Cusip	46120E602
Employees	17,021
Employees Change	1,383%
Employees Change Percent	8.84
Enterprise value	$154.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500, NASDAQ100
Industry	Medical Instruments & Supplies
IPO Date	2000-06-13
Isin	US46120E6023
Last refreshed	2026-05-10
Market cap	$159.4B
Market cap category	Large-Cap
Price	$450
Price currency	USD
Rev Per Employee	621,708.48x
Sector	Healthcare
Sic	3842
Symbol	ISRG
Tags	artificial-intelligence, robotics
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.87%
EV Earnings	51.99x
EV Sales Forward	12.75x
EV/EBIT	48.06x
EV/EBITDA	39.86x
EV/FCF	54.64x
EV/Sales	14.64x
FCF yield	1.78%
Forward P/E	42.3x
P/B ratio	9.13x
P/E ratio	54.69x
P/S ratio	15.06x
PE Ratio10 Y	61.61x
PE Ratio3 Y	71.02x
PE Ratio5 Y	68.43x
PEG ratio	2.72x
PS Forward	13.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.45%
EBITDA Margin	36.72%
FCF margin	26.78%
Gross margin	66.29%
Gross Profit	$7B
Gross Profit Growth	19.99%
Gross Profit Growth Q	25.57%
Gross Profit Growth3 Y	17.73%
Gross Profit Growth5 Y	18.32%
Net Income	$3B
Net Income Growth	20.31%
Net Income Growth Q	17.63%
Net Income Growth Quarters	12%
Net Income Growth Years	3%
Net Income Growth3 Y	31.44%
Net Income Growth5 Y	20.48%
Pretax Margin	33.86%
Profit Margin	28.15%
Profit Per Employee	$175,025
Profitable Years	22
ROA	10.24
Roa5y	8.5
ROCE	17.71
ROE	17.23
Roe5y	14.94
ROIC	21.36
Roic5y	21.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.67%
Cagr15y	17.77%
Cagr1y	-16.07%
Cagr20y	18.86%
Cagr3y	13.86%
Cagr5y	9.52%
EPS Growth	20.47
EPS Growth Q	18.75
EPS Growth Quarters	12
EPS Growth Years	3
EPS Growth3 Y	31.16
EPS Growth5 Y	20.49
FCF Growth	62.4%
FCF Growth Q	73.89%
FCF Growth3 Y	41.22%
FCF Growth5 Y	16.61%
OCF Growth	23.05%
OCF Growth Q	56.79%
OCF Growth10 Y	14.4%
OCF Growth3 Y	27.04%
OCF Growth5 Y	15.86%
Revenue Growth	21.43x
Revenue Growth Q	22.96x
Revenue Growth Quarters	22x
Revenue Growth Years	5x
Revenue Growth3 Y	18.06x
Revenue Growth5 Y	18.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$20.1B
Cash	$4.5B
Current Assets	$8.8B
Current Liabilities	$1.9B
Equity	$17.6B
Liabilities	$2.5B
Long Term Assets	$11.3B
Long Term Liabilities	$602.8M
Net Cash	$4.5B
Net Cash By Market Cap	$2.83
Net Cash Growth	0.13%
Net Debt EBITDA	$-1.16
Net Debt Equity	$-0.26
Net Debt FCF	$-1.59
Tangible Book Value	$16.7B
Tangible Book Value Per Share	$47.09
WACC	12.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.61
Inventory Turnover	2.04
Net Working Capital	$2.4B
Quick ratio	3.26
Working Capital	$6.9B
Working Capital Turnover	$1.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	554.41%
1Y total return	-16.06%
200-day SMA	498.6
3Y total return	47.62%
50-day SMA	470.1
50-day SMA vs 200-day SMA	50under200
5Y total return	57.53%
All Time High	616
All Time High Change	-26.94%
All Time High Date	2025-01-23
All Time Low	0.67
All Time Low Change	67,405.62%
All Time Low Date	2001-04-03
ATR	12.63
Beta	1.51
Beta1y	1.04
Beta2y	1.09
Ch YTD	-20.53
High	454.3
High52	603.9
High52 Date	2026-01-07
High52ch	-25.47%
Low	447
Low52	427.8
Low52 Date	2025-10-14
Low52ch	5.2%
Ma50ch	-4.26%
Premarket Change Percent	0
Premarket Price	$453
Premarket Volume	24,502
Price vs 200-day SMA	-9.74%
RSI	41.76
RSI Monthly	47.18
RSI Weekly	39.39
Sharpe ratio	-0.59x
Sortino ratio	-0.7
Total Return	0.42%
Tr YTD	-20.53
Tr15y	1,062.68%
Tr1m	-0.64%
Tr1w	-1.69%
Tr3m	-7.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Ratings	Buy
Earnings EPS Estimate	$1.92
Earnings EPS Estimate Growth	6.08
Earnings Revenue Estimate	2,614,789,698x
Earnings Revenue Estimate Growth	16.06x
Operating Income	$3.2B
Operating Income Growth	31.13
Operating Income Growth Q	47.95
Operating Income Growth3 Y	26.69
Operating Income Growth5 Y	22.18
Operating margin	30.45
Price target	$591
Price Target Change	$31.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	351,968,623%
Float Percent	99.38%
Shares Insiders	0.52%
Shares Institutions	86.24%
Shares Out	354,162,842
Shares Qo Q	-0.17%
Shares Yo Y	-0.42%
Short Float	1.89%
Short Ratio	4.03
Short Shares	1.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2B
Average Volume	2,302,977.5x
Bv Per Share	49.31
CAPEX	$-526.5M
Ch10y	554.4
Ch15y	1,062.7
Ch1m	-0.64
Ch1w	-1.69
Ch1y	-16.06
Ch20y	3,068.8
Ch3m	-7.8
Ch3y	47.62
Ch5y	57.53
Ch6m	-19.63
Change	-0.76%
Change From Open	-0.94
Close	453.5
Days Gap	0.18
Depreciation Amortization	662,900,000
Dollar Volume	1,081,168,336.6
Earnings Date	2026-04-21
Earnings Time	amc
EBIT	$3.2B
EBITDA	$3.9B
EPS	$8.23
F Score	5
FCF	$2.8B
FCF EV Yield	1.83x
FCF Per Share	$8
Financing CF	-3,482,000,000
Fiscal Year End	December
Founded	1,995
Goodwill	613,200,000
Graham Number	95.54735
Graham Upside	-78.77
Income Tax	$584.4M
Investing CF	-462,200,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-21
Last Report Date	2026-03-31
Last Split Date	2021-10-05
Last Split Type	Forward
Last10k Filing Date	2026-02-03
Lynch Fair Value	$169
Lynch Upside	-62.55
Ma150	509.9
Ma150ch	-11.74%
Ma20	462.5
Ma20ch	-2.68%
Net CF	-565,100,000
Next Earnings Date	2026-07-21
Open	454.3
Optionable	Yes
P FCF Ratio	56.24
P OCF Ratio	47.43
Position In Range	41.8
Post Close	450.1
Postmarket Change Percent	0.21
Postmarket Price	$451
Ppne	5,447,900,000
Pre Close	453.5
Price Date	2026-05-08
Price EBITDA	$41.02
Ptbv Ratio	9.55
Relative Volume	1.04x
Revenue	10,582,100,000x
SBC By Revenue	7.68x
Share Based Comp	812,500,000
Tax By Revenue	5.52x
Tax Rate	16.31%
Tr20y	3,068.69%
Tr6m	-19.63%
Us State	California
Views	140
Volume	2,402,276
Z Score	45.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

9/10

Business quality stays separate from stock attractiveness.

Forward P/E

38.2x

Valuation uses the full report model stack, not a single multiple.

Next action

Sell

Final action steps are kept in the recommendation tab.

Our take

Income

Does ISRG pay a dividend?

Capital-return profile for this ticker.

Performance

ISRG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ISRG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.2%

Float: +99.4% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ISRG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.8

Neutral momentum band

Price vs 200-day MA

-9.7%

50/200-day relationship not available

Beta (5Y)

1.51

More volatile than the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

ISRG vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.3T	35.6x	9.5x	104.3%	+6.8%	+50.1%	売り
ABNB	Airbnb Inc.	84B	34.7x	6.6x	15.9%	+29.9%	+14.9%	ホールド
ADBE	Adobe Inc.	102.3B	14.8x	4.2x	63.3%	+12.3%	-34.3%	強い買い

Questions

About ISRG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ISRG stock rating?

Intuitive Surgical, Inc. is currently shown with Sell in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ISRG analysis?

The full report lives at /stocks/ISRG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ISRG?

The latest report frames ISRG around $176 to $337. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ISRG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.